Ticker brief
LFMD
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
8
authors 14d
5
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-07-02 · now +0.18 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @apex_actuary | C | +0.35 | 4 | +0.24 |
| @himshouse | C | +2.91 | 1 | +0.35 |
| @carlosfagar | C | +2.84 | 1 | +0.55 |
| @PrismMarketView | C | · | 1 | +0.20 |
| @MacGillivrayCPA | C | +1.23 | 1 | +0.15 |
Recent signals8of 8 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-02 | @MacGillivrayCPA | +0.15 | Author will attend July 23 FDA meeting on recategorization of peptides; relevant peptide-exposed tickers listed. | · | tweet ↗ |
| 2026-07-02 | @PrismMarketView | +0.20 | Mid-day movers list with percentage moves for weight loss and biotech names. | · | tweet ↗ |
| 2026-07-02 | @apex_actuary | +0.20 | Discloses rotation out of OSCR and PEPE into CELH plus portfolio weights. | · | tweet ↗ |
| 2026-07-01 | @apex_actuary | +0.55 | Thinks LFMD can reach $10-12 this year despite not loving chart. | · | tweet ↗ |
| 2026-07-01 | @apex_actuary | +0.10 | Implies holding only LFMD, with discomfort. | · | tweet ↗ |
| 2026-06-26 | @apex_actuary | +0.10 | DCA Friday: Hold. — States DCA action is hold across listed names. | · | tweet ↗ |
| 2026-06-23 | @carlosfagar | +0.55 | Author calls OSCR, LFMD, and DUOL today's stars of their portfolio. | · | tweet ↗ |
| 2026-06-22 | @himshouse | +0.35 | LifeMD launches self-pay XYOSTED testosterone program in July 2026 across 37 states. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.